A topical treatment combining calcipotriol and 5-FU shows promise in reducing premalignant lesions and lowering skin cancer ...

“This project funding is crucial for advancing the cream through pre-clinical development ... with the potential not only to prevent the onset of skin cancer but also to treat early-stage ...

The best hand creams for dry skin treat a concern that’s hardly rare. “Dry, chapped hands are one of the most common issues that I see in clinic,” affirms Courtney Rubin, board-certified ...

Study: T helper 2 cell–directed immunotherapy eliminates precancerous skin lesions. Image Credit: Me dia/Shutterstock.com Skin cancer rates are increasing globally, driving research into new ...

Dr. Demehri and his team enrolled 18 patients to evaluate the mechanism behind a topical immunotherapy treatment on precancerous skin lesions. Here are five notes from the study: The topical ...

However, my trusty Hershesons Everything Cream eventually came to my aid and in no time, I remembered just how much I love the best hair creams. As much as I adore Hershesons one, it's not the ...

That's how my eczema-prone skin appeared (and felt) as soon as it was graced with this cream. It had just the right amount of shimmer without looking greasy, and I couldn't believe how quickly my ...

Abstract: Skin lesion segmentation is critical in medical image processing, but the segmentation task faces numerous challenges due to the differences in size, color, shape, and texture of skin ...

It enrolled 18 subjects with qualifying pre-cancerous skin lesions. Subjects applied a therapy that combines 0.0025% calcipotriol and 2.5% 5-FU to affected areas twice a day for six days.

Demehri's team conducted an open-label clinical trial to investigate the mechanism of calcipotriol plus 5-FU immunotherapy. Eighteen patients with qualifying precancerous skin lesions were enrolled.

The therapy combines topical calcipotriol with 5-fluorouracil and has been shown to eliminate pre-cancerous lesions. Credit: Evgeniia Primavera / Shutterstock. Investigators at Mass General Brigham in ...